Five Prime Therapeutics Stock News

BVF Inc. IL boosted its holdings in Five Prime Therapeutics Inc (NASDAQ:FPRX) by 106.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The in

Charles Schwab Investment Management Inc. lessened its holdings in shares of Five Prime Therapeutics Inc (NASDAQ:FPRX) by 2.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 211,

Five Prime Therapeutics (NASDAQ:FPRX) and ZEALAND PHARMA/S (NASDAQ:ZEAL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the stren

Barclays PLC raised its position in Five Prime Therapeutics Inc (NASDAQ:FPRX) by 45.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). Th

Q4 2019 Five Prime Therapeutics Inc Earnings Call

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commen

Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Five Prime Therapeutics Inc (NASDAQ:FPRX) during the fourth quarter, according to its most recent 13F filing with the S

Q4 2019 Five Prime Therapeutics Inc Earnings Call

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study in the Journal of Clinical Oncology

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...

During Wednesday's morning session, 690 stocks hit new 52-week lows. Intriguing Points: Boeing (NYSE: BA) was the biggest company on a market cap basis to set a new...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu

Alambic Investment Management L.P. raised its stake in shares of Five Prime Therapeutics Inc (NASDAQ:FPRX) by 132.4% in the fourth quarter, according to its most recent Form 13F filing with the Securi

Wall Street brokerages predict that Five Prime Therapeutics Inc (NASDAQ:FPRX) will post sales of $5.90 million for the current quarter, Zacks Investment Research reports. Five analysts have made estim